Evenly unique as attractive

State-of-the-art

The Microsieve technology distinguishes itself through simplifying pivotal steps in the manufacturing of microspheres and nanoparticles, which makes production:

• Reproducible: Total control of droplet & particle size, yielding products with the required size and uniformity without process or formulation optimization.
• Economic: No loss of valuable ingredients, no post-process fractionation necessary.
• Robust: The process is insensitive to fluidic and pressure conditions near the membrane surface and fit for many biodegradable polymers such as PLGA, PLLA, PLGA-PEG, PLGA-PCL, PMMA and PEG-PBT
• Scalable: We have proven the scalability of the technology by bringing several aseptic production processes to full commercial scale – under GMP.
• Versatile: Each droplet is formed individually at negligible imposed shear and pressure, making it suitable for encapsulation of a wide range of pharmaceutical compounds, including antibodies, hormones, small molecules and cytostatic compounds.